Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome

NCT06271538 PHASE4 RECRUITING

The objective of this randomized, double-blind, placebo-controlled study is to evaluate the effectiveness of Skal Pro in alleviating symptoms, enhancing stool consistency, improving quality of life, and addressing psychological distress in individuals diagnosed with irritable bowel syndrome (IBS), as compared to those who receive no intervention.

Details

Lead sponsor	EP Plus Group Sdn Bhd
Phase	PHASE4
Status	RECRUITING
Enrolment	60
Start date	Thu Oct 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun Nov 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Irritable Bowel Syndrome
• Gastrointestinal Diseases
• Colonic Diseases, Functional
• Intestinal Disease
• Digestive System Disease
• Pathologic Processes
• Colonic Disease
• Disease

Interventions

• Skal Pro
• Placebo

Countries

Malaysia